Managing and Monitoring Immunotherapy Side Effects
Immunotherapy – the use of medications that improve the immune system’s response to cancer cells – continues to evolve as
HIPAA Alert: Potential Data Breach Learn More
Questions on Oncology, Hematology and/or Infusion Clinical Services due to COVID-19 Crisis – CALL 833-698-1623
Important Information for Our Patients Regarding the Coronavirus.
RCCA Providing Area Cancer Patients with Access to Care During Coronavirus Outbreak
RCCA Offering Patients Virtual Visits During Coronavirus Pandemic
We’re here for you. Call us at 844-346-7222 or
Immunotherapy – the use of medications that improve the immune system’s response to cancer cells – continues to evolve as
The RCCA Howell, NJ division has had another great year collecting for the Howell Police Department Adopt a Family program.
When it comes to breast cancer, early detection is the key to a higher chance of a positive outcome. According
Dr. Andre Goy, Chief Science Officer and Director of Research and Innovation for Regional Cancer Care Associates, won the 2019
Breast cancer is prevalent in the United States, so many women will undergo a single or double mastectomy in their
As medicine continues to evolve, those who have been diagnosed with cancer have more treatment options than ever. But after
You don’t smoke, and you’ve never smoked in your life – but you’ve been diagnosed with lung cancer. How did
The earlier breast cancer is detected, the greater the likelihood of survival. It is a straightforward concept, one that is
Deciding whether to participate in a clinical trial can be difficult, even if your oncologist recommends it. Ultimately, it’s your
For more information or to schedule an appointment, call (844) 346-7222. You can also schedule an appointment by calling the RCCA location nearest you.
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.